Correlation Between ARCA Biopharma and Albireo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and Albireo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and Albireo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARCA Biopharma and Albireo Pharma, you can compare the effects of market volatilities on ARCA Biopharma and Albireo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of Albireo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and Albireo Pharma.

Diversification Opportunities for ARCA Biopharma and Albireo Pharma

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between ARCA and Albireo is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and Albireo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albireo Pharma and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with Albireo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albireo Pharma has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and Albireo Pharma go up and down completely randomly.

Pair Corralation between ARCA Biopharma and Albireo Pharma

Given the investment horizon of 90 days ARCA Biopharma is expected to under-perform the Albireo Pharma. But the stock apears to be less risky and, when comparing its historical volatility, ARCA Biopharma is 7.68 times less risky than Albireo Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Albireo Pharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2,201  in Albireo Pharma on December 20, 2023 and sell it today you would earn a total of  2,214  from holding Albireo Pharma or generate 100.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy20.43%
ValuesDaily Returns

ARCA Biopharma  vs.  Albireo Pharma

 Performance 
       Timeline  
ARCA Biopharma 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days ARCA Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, ARCA Biopharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Albireo Pharma 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Albireo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Albireo Pharma is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

ARCA Biopharma and Albireo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ARCA Biopharma and Albireo Pharma

The main advantage of trading using opposite ARCA Biopharma and Albireo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, Albireo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will offset losses from the drop in Albireo Pharma's long position.
The idea behind ARCA Biopharma and Albireo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity